Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989)
Market Closed
2 Oct, 08:00 AM
HKEX HKEX Primary 
OTC PINK 3. 83
HKD -0.23
-5.672%
15.78B Market Cap
- P/E Ratio
- Div Yield
192,500 Volume
- Eps
4.05 HKD
Previous Close Want to track 9989 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989) Statistics
Valuation metrics
Market Cap 15.78B
Enterprise value 13.84B
Trailing P/E (ttm) 66.76
Forward P/E -
PEG ratio -1.34
Price/Sales (ttm) 2.37
Price/Book (mrq) 1.15
Enterprise Value/Revenue 2.64
Enterprise Value/EBITDA 23.55
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 575.25K
Average volume (90 days) 552.31K
Price summary
52-Week low 3.74
52-Week high 5.77
Beta -
50-Day moving average 4.1
200-Day moving average 4.37
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.14
Trailing annual dividend yield 0.0156%
5-Year annual dividend yield -
Payout ratio 1.22
Dividend Date 18 Jun 2026
Ex-Dividend Date 27 May 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.04%
Operating margin 0.09%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.57
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.14
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.42
Total debt (mrq) -
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 2.31%
Book value per share (mrq) 8.19
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
